Internal Medicine, Hematology & Oncology · Weslaco, TX
NPI
1639116288
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1330 E 6th St, Suite 204
Weslaco, TX, 78596
Phone (956) 969-0021
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
88,735 services
Medicare patients, 2024
317
Average age 75
Drug cost, 2024
$7.8M
2,694 prescriptions
Company payments, 2025
$810
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel Farray-Berges was code J1756 (injection, iron sucrose, 1 mg), 7,800 times for 12 patients. In total Daniel Farray-Berges billed 88,735 services in 139 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-10-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1756 Injection, iron sucrose, 1 mg | Office | 7,800 | 12 | $0.17 | $1,328 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 7,540 | 16 | $2.30 | $17K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 5,700 | 13 | $0.11 | $634 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 877 | 26 | $0.09 | $78.54 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 840 | 18 | $0.24 | $206 |
| 85025 Blood Count | Office | 726 | 210 | $7.61 | $5,525 |
| 36415 Venipuncture Blood Collection | Office | 645 | 187 | $8.65 | $5,579 |
| 80053 Clinical Chemistry | Office | 440 | 164 | $10.35 | $4,554 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 420 | 14 | $0.72 | $304 |
| 99214 Office E&M - Established | Office | 316 | 106 | $88.58 | $28K |
| 99213 Office E&M - Established | Office | 247 | 164 | $60.10 | $15K |
| 96413 Chemotherapy Administration | Office | 209 | 43 | $92.70 | $19K |
| 96367 Intravenous Infusion, Hydration | Office | 126 | 30 | $20.31 | $2,559 |
| 96375 Injection Administration | Office | 119 | 27 | $11.19 | $1,331 |
| 96372 Injection Administration | Office | 104 | 26 | $10.40 | $1,082 |
By year: 2022 $1.9M for 102,264 services; 2023 $1.6M for 84,060 services; 2024 $1.5M for 88,735 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 726 | 210 | $7.61 | $5,525 |
| 36415 Venipuncture Blood Collection | 645 | 187 | $8.65 | $5,579 |
| 80053 Clinical Chemistry | 440 | 164 | $10.35 | $4,554 |
| 82728 Clinical Chemistry | 54 | 32 | $13.36 | $721 |
| 83540 Clinical Chemistry | 51 | 31 | $6.34 | $323 |
| 83550 Clinical Chemistry | 51 | 31 | $8.57 | $437 |
| 83615 Clinical Chemistry | 39 | 32 | $5.92 | $231 |
| 84153 Clinical Chemistry | 24 | 12 | $18.02 | $432 |
| 85007 Blood Count | 18 | 12 | $3.72 | $66.96 |
| 85027 Blood Count | 18 | 12 | $6.34 | $114 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel Farray-Berges prescribed most often to Medicare patients was Anastrozole, with 275 prescriptions and refills. In total Daniel Farray-Berges wrote 2,694 Medicare prescriptions that cost $7.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 275 | 575 | 69 | $4,869 |
| Gabapentin Generic | 119 | 159 | 38 | $1,711 |
| Prednisone Generic | 82 | 102 | 25 | $437 |
| Dexamethasone Generic | 78 | 87 | 38 | $1,398 |
| Revlimid Lenalidomide | 77 | 77 | 11 | $1.1M |
| Ondansetron Hcl Generic | 75 | 75 | 31 | $1,086 |
| Levothyroxine Sodium Generic | 74 | 156 | 27 | $1,682 |
| Olanzapine Generic | 67 | 69 | 36 | $517 |
| Exemestane Generic | 64 | 130 | 20 | $10K |
| Letrozole Generic | 53 | 90 | 14 | $996 |
| Alendronate Sodium Generic | 51 | 121 | 15 | $393 |
| Promacta Eltrombopag Olamine | 50 | 52 | Under 11 | $346K |
| Ibrance Palbociclib | 50 | 50 | Under 11 | $773K |
| Hydroxyurea Generic | 48 | 106 | 15 | $1,392 |
| Verzenio Abemaciclib | 46 | 46 | Under 11 | $687K |
Brand drugs: 573 claims; generic drugs: 2,121 claims; opioid claims: 116.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel Farray-Berges $810 ($810 in general payments such as food, travel and fees) from 15 companies. The largest payer was Pfizer Inc. with $189.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 4 | $189 |
| Boston Scientific Corporation BSX | 1 | $138 |
| Janssen Biotech, Inc. JNJ | 1 | $79.96 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $68.49 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $68.15 |
| GlaxoSmithKline, LLC. GSK | 4 | $67.99 |
| Genentech USA, Inc. ROG.SW | 2 | $44.09 |
| Celgene Corporation BMY | 1 | $32.03 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $23.65 |
| Amgen Inc. AMGN | 1 | $23.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.